QBREXZA tv commercials
TV spots
TV commercials QBREXZA
The QBREXZA TV spot features aspiring singer ArJay K. who is giving an interview with Jessie James Decker. ArJay K. shares his story about his excessive sweating problem and how it used to hinder his dreams of becoming a successful singer. He explains how he had tried numerous remedies before but no...
The QBREXZA TV spot titled 'Chelsea B: Aspiring Singer' is a heartwarming advertisement that highlights the challenges faced by people who suffer from excessive underarm sweating. The ad features Chelsea B, a young woman who aspires to be a singer but struggles with the embarrassing and uncomfortabl...
The QBREXZA TV Spot featuring Jessie James Decker is a motivational and uplifting commercial that aims to encourage viewers to "move forward" and overcome the obstacles that may be hindering their daily lives. The commercial starts with Jessie James Decker, a popular country singer, opening up about...
Introducing the QBREXZA TV Spot: 'See What Unfolds': In a world of constant movement and endless possibilities, there's one thing that binds us all together – sweat.: For those who live with excessive sweating, every moment can be a challenge.: But what if there was a solution that allowed you to em...
Actors
Actors who starred in QBREXZA commercials
What kind of company is QBREXZA?
IntroductionQbrexza is a prescription medication that is used on the skin to treat excessive underarm sweating , also known as primary axillary hyperhidrosis. It is manufactured by Dermira, a biopharmaceutical company.
About DermiraDermira, a wholly-owned subsidiary of Eli Lilly and Company, is a biopharmaceutical company that focuses on developing innovative therapies for patients living with dermatologic conditions. Its mission is to improve the lives of patients by bringing new therapies to the market.
Qbrexza as a Treatment for HyperhidrosisQbrexza, which is made up of glycopyrronium, is an anticholinergic indicated for topical use only. It is the first and only cloth approved by the US Food and Drug Administration for the treatment of primary axillary hyperhidrosis. In clinical studies, Qbrexza has been shown to significantly reduce sweating in patients with primary axillary hyperhidrosis.
Qbrexza and Dermira's Armpit Awareness PushDermira has launched an awareness campaign to raise awareness about excessive underarm sweating and the potential treatment options available. The company has also partnered with several healthcare providers to educate patients about primary axillary hyperhidrosis and Qbrexza.
ConclusionQbrexza is a promising treatment option for patients with primary axillary hyperhidrosis. The medication, manufactured by Dermira, is the first and only cloth approved by the US FDA for the treatment of excessive underarm sweating. With the company's armpit awareness push , more patients can be educated about this condition and the potential treatment options available to them.
